Pancreatic Adenocarcinoma — Trials

Pancreatic Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

915 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 356
Recruiting: 209
Ph III recruiting: 23
Growth YoY: +41.4%
Industry share: 41%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (136)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07262957	Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)(PANENCA)	recruiting	Phase 4	400	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER	1	Dec 22, 2025	clinicaltrials

Data updated 22 days agoSource updated Dec 22, 2025source: clinicaltrials